Skip to content

A clinical trial to study the effect of Kanakasava Nebulizer Solution in Patients with COPD

An open labelled randomized active controlled evaluation of effect Of Kanakasava nebulizer solution in chronic obstructive pulmonary disease(COPD)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045966
Enrollment
72
Registered
2022-09-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

None listed

Sponsors

Dean Faculty of Ayurved Parul University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients between age group 18 to 60 years (both years inclusive) of either gender. 2 Patients diagnosed with Mild to Moderate COPD as per GOLD Guidelines 2020. 3 Patients with symptom of Shwaskashta (Dyspnea) even while resting. 4 Willing and able to give written informed consent.

Exclusion criteria

Exclusion criteria: 1 Pregnant or Lactating women 2 History of any chronic respiratory disease other than COPD 3 Patients with known case of Systemic Diseases like Uncontrolled Diabetes and Hypertension. 4 Severe cases of COPD as per GOLD guidelines 2020. 5 History of upper or lower respiratory tract infection, within the previous 30 days. 6 History of lung resection of more than one full lobe. 7 Have a known sensitivity to formoterol, ipratropium, salbutamol. 8 Immunocompromised status such as HIV.

Design outcomes

Primary

MeasureTime frame
Effect on COPD on the basis of FEV1( through spirometry) Effect on COPD on the basis of Peak flow meterTimepoint: Assessment at baseline(0 hour) and at the end of 24 hours Assessment at baseline(0 hour), 6 hour, 18 hour and the end of 24 hours

Secondary

MeasureTime frame
Effect on COPD on the basis of CAT Score Effect on COPD on the basis of symptom of Shwasakashta(dyspnea)Timepoint: Assessment at baseline(0 hour), 6 hour, 18 hour and the end of 24 hours Assessment at baseline(0 hour), 6 hour, 18 hour and the end of 24 hours

Countries

India

Contacts

Public ContactDr Vaishali S Deshpande

Parul Institute of Ayurveda

dr.shaileshd@gmail.com9763104451

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026